September 18, 2024 10:44 PM EDTUpdated 06:49 AM

Tang Capital’s Concentra bids for Singular Genomics days after Deerfield offer

Jared Whitlock

Features Editor

A second buyer has made an offer to buy the DNA sequencing company Singular Genomics Systems, potentially complicating an offer made last week by the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Tang Capital’s Concentra bids for Singular Genomics days after Deerfield offer

Jared Whitlock

Features Editor

Sign up to read this article for free.

Sr. Manager/Associate Director, Document Control

Viridian Therapeutics

Waltham, MA, USA

Stem cell startup spun out of George Church’s lab raises $75M

Here's what today's Fed rate cut means for biotech, pharma and venture capital

FDA rejects Vanda’s treatment for digestion condition, company rebukes agency's actions

Edgewise’s stock surges as heart drug passes early safety test

Exclusive: Flagship-backed Valo Health loses interim CEO ahead of key Phase 2 readout

Breaking down silos with a new quantitative approach to drug development

Tang Cap­i­tal’s Con­cen­tra bids for Sin­gu­lar Ge­nomics days af­ter Deer­field of­fer

Features Editor

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

Tang Capital’s Concentra bids for Singular Genomics days after Deerfield offer